10 BÜCHER, DIE MIT «ACE INHIBITOR» IM ZUSAMMENHANG STEHEN
Entdecke den Gebrauch von
ACE inhibitor in der folgenden bibliographischen Auswahl. Bücher, die mit
ACE inhibitor im Zusammenhang stehen und kurze Auszüge derselben, um seinen Gebrauch in der Literatur kontextbezogen darzustellen.
1
Pharmacotherapeutics for Advanced Practice: A Practical Approach
When pregnancy is detected, the ACE inhibitor should be discontinued
immediately. Adverse Events The most common adverse reactions of ACE
inhibitors are dizziness, headache, fatigue, diarrhea, cough, and hypotension.
Angioedema of ...
Virginia Poole Arcangelo, Andrew M. Peterson, 2006
2
Getting a Good Night's Sleep
The ACE-inhibitor's effect is beneficial for patients whose heart has been
damaged, thus weakened, by a heart attack. With an ACE-inhibitor, resistance to
heart pumping is reduced, and blood flow and oxygenation of the tissues are
improved.
Nancy Foldvary-Schaefer, 2006
3
Hypertension Primer: The Essentials of High Blood Pressure
There is no evidence to support switching from an ACE inhibitor to an ARB if the
former has failed. High-risk cardiac patients. In HOPE, low-dose ramipril (2.5 mg/
day) was ineffective at preventing cardiovascular events; in general, higher ...
Joseph L. Izzo, Henry Richard Black, Council for High Blood Pressure Research (American Heart Association), 2003
4
Meyler's Side Effects of Cardiovascular Drugs
According to the authors, high transcriptional activity of the bradykinin B2
receptor promoter may be related to the risk of ACE inhibitor-related cough. This
is the first demonstration that a genetic variant is involved in ACE inhibitor-related
cough ...
5
Hypertension: A Companion to Braunwald's Heart Disease
Hypoperfusion ACE Inhibitor Treated Conditions Causing Hypoperfusion
Hypotension Renal arterial disease Dehydration Congestive heart failure Afferent
arteriole (decreased flow) Efferent arteriole (constricted) Afferent arteriole (
decreased ...
William J. Elliott (M.D.), 2007
6
Cardiovascular Therapeutics: A Companion to Braunwald's ...
However, adding a thiazide, even in small doses, to ACE inhibitor therapy
enhances the antihypertensive efficacy of the ACE inhibitor, because diuretic-
induced sodium depletion activates the reninangiotensin-aldosterone system
and makes ...
7
Geriatric Emergency Medicine
This is now thought to be nearly 80% [89]. Generally ACE inhibitor angioedema
is a self-limited, non-pitting swelling of the head, neck, lips, mouth, tongue, larynx,
pharynx, and subglottal areas [90,91]. In contrast to allergic angioedema, there ...
Joseph H. Kahn, Brendan G. Magauran, Jr, Jonathan S. Olshaker, 2014
8
Renin Angiotensin System and Cardiovascular Disease
As in ELITE 2, the best outcomes were achieved with the older more established
ACE inhibitor regimen. Fortunately, this concept of ACE inhibitor versus ARB was
further tested in the VALIANT trial evaluating a different ARB (valsartan, target ...
Walmor C. DeMello, Edward D. Frohlich, 2009
9
Joslin's Diabetes Mellitus: Edited by C. Ronald Kahn ... [et ...
preservation of renal function than did those receiving an anti- hypertensive
regimen that excluded an ACE inhibitor, although, as in several other clinical
trials, the mean systemic blood pressure was lower in the enalapril group (110).
Another ...
Elliott Proctor Joslin, C. Ronald Kahn, 2005
10
Cardiac Intensive Care
The angioedema caused by ACE inhibitor and ARB therapy is thought to be
related to the kinin pathway rather than mast-cell degranulation. Urticaria and
pruritus are usually not present in angioedema caused by the kinin pathway.
Allen Jeremias, David Lloyd Brown, 2010
10 NACHRICHTEN, IN DENEN DER BEGRIFF «ACE INHIBITOR» VORKOMMT
Erfahre, worüber man in den einheimischen und internationalen Medien spricht und wie der Begriff
ACE inhibitor im Kontext der folgenden Nachrichten gebraucht wird.
Company Shares of SciClone Pharmaceuticals, Inc. Rally 18.16%
SciClones marketed portfolio also includes Depakine, the prescribed broad-spectrum anti-convulsant in China; Tritace, an ACE inhibitor for the ... «Insider Trading Report, Jul 15»
Analyst Price Target Update on Dyax Corp.
... conditions identified as plasma kallikrein (bradykinin) mediated angioedema, including hereditary angioedema (HAE), ACE inhibitor-induced ... «Money Flow Index, Jul 15»
Analyst Price Target Update on SciClone Pharmaceuticals, Inc.
SciClones marketed portfolio also includes Depakine, the prescribed broad-spectrum anti-convulsant in China; Tritace, an ACE inhibitor for the treatment of ... «OTC Outlook, Jul 15»
Sciclone Pharmaceuticals Inc (SCLN) Files Form 4 Insider Selling …
SciClone's marketed portfolio also includes Depakine, the prescribed broad-spectrum anti-convulsant in China; Tritace, an ACE inhibitor for the ... «Insider Trading Report, Jun 15»
Company Shares of Dyax Corp. Drops by -2.47%
... conditions identified as plasma kallikrein (bradykinin) mediated angioedema, including hereditary angioedema (HAE), ACE inhibitor-induced ... «American Trade Journal, Jun 15»
Younger, older HF patients require different disease management
Additionally, the younger group was less likely to receive IV diuretics, statin and beta blockers, but more likely to receive ace inhibitor and ... «Healio, Jun 15»
Specialist care benefitted medically complex type 2 diabetes
... endocrinologist care group being more likely to receive a statin (P < .001), an ACE inhibitor or angiotensin receptor blocker (P <.001) and two ... «Healio, Jun 15»
Dyax Corp. Short Interest Update
... conditions identified as plasma kallikrein (bradykinin) mediated angioedema, including hereditary angioedema (HAE), ACE inhibitor-induced ... «American Trade Journal, Jun 15»
Sciclone Pharmaceuticals Inc (SCLN) Discloses SEC Form 4 Insider …
SciClone's marketed portfolio also includes Depakine, the prescribed broad-spectrum anti-convulsant in China; Tritace, an ACE inhibitor for the ... «Money Flow Index, Jun 15»
Zacks Short Term Rating on SciClone Pharmaceuticals, Inc …
SciClones marketed portfolio also includes Depakine, the prescribed broad-spectrum anti-convulsant in China; Tritace, an ACE inhibitor for the ... «American Trade Journal, Jun 15»
